EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations



Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations



Journal of Cancer Research and Clinical Oncology 133(6): 361-371



Purpose The present study aims to assess the incidence of microsatellite instability (MSI) and mutations in the PTEN and beta-catenin (CTNNB1) genes in endometrial carcinomas and to analyze the detected defects in these factors in relation to each other and to the clinico-pathological features of tumors. Materials and methods In a series of 56 endometrioid endometrial carcinomas, the status of MSI was determined using nine polymorphic markers, and mutations in all exons of the PTEN gene and in exon 3 of the CTNNB1 gene were evaluated by SSCP and sequencing methods. Results Microsatellite instability was found in 18 carcinomas (32.1%, MSI+); the remaining 38 tumors were microsatellite stable (MSI-). In 15 cases (26.8%), a loss of heterozygosity (LOH) at the studied microsatellite markers also occurred. In 29 carcinomas (51.8%), mutations were found in the PTEN gene and in nine tumors (16.1%) in the CTNNB1 gene. PTEN mutations occurred significantly more frequently in MSI+ than in MSI- tumors (77.8 vs. 39.5%, p = 0.007), but, except for one, none of them was attributable to MSI. In contrast, incidence of CTNNB1 mutations in MSI+ and MSI- tumors no significantly differed between themselves (16.7 vs. 15.8%, p = 0.760). Interestingly, mutations in the CTNNB1 gene most frequently coexisted with mutations in the PTEN gene (7/9, 77.8%). However, this finding requires future verification on a larger group of cases. The incidence of MSI and PTEN, but not CTNNB1 mutations, was significantly more common in poorly, than in well-to-moderately, differentiated tumors (G3 vs. G1 + G2; p = 0.042, 0.039 and 0.958, respectively). Conclusion We conclude that most frequently occurring mutations in the PTEN gene may be a key event for the tumorigenesis of endometrioid endometrial carcinomas, while coexistence or absence of microsatellite instability or mutations in the CTNNB1 gene may reflect the heterogeneity of molecular mechanisms contributing to the development of these tumors.

(PDF emailed within 0-6 h: $19.90)

Accession: 013763118

Download citation: RISBibTeXText

PMID: 17219201

DOI: 10.1007/s00432-006-0179-4



Related references

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagnostic Molecular Pathology 10(2): 116-122, 2001

Beta-catenin mutations and expression in endometrial carcinomas with and without microsatellite instability. Laboratory Investigation 81(1): 140A, January, 2001

Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Research 59(14): 3346-3351, 1999

Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Human Pathology 35(11): 1360-1368, 2005

Mutations in the PTEN and beta-catenin genes and in microsatellite sequences are a feature of endometrioid endometrial cancers. Gynecologic Oncology 72(3): 467, March, 1999

CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Human Pathology 33(2): 206-212, 2002

PTEN mutations do not cause nuclear beta-catenin accumulation in endometrial carcinomas. Human Pathology 35(10): 1260-1265, 2004

Frameshift mutations at target genes in endometrial carcinomas with microsatellite instability. Modern Pathology 16(1): 185A, January, 2003

LOSS of PTEN immunoreactivity is frequent in endometrial carcinomas with clear cell changes independent of LOH at 10q23, microsatellite instability and other molecular alterations. Pathology Research & Practice 198(3): 239, 2002

Beta-catenin mutations, microsatellite instability, and hMLH1 alterations in ovarian endometrioid carcinomas. Modern Pathology 16(1): 184A-185A, January, 2003

Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Research 55(23): 5556-5560, 1995

Evidence for different expression profiles for c-Met, EGFR, PTEN and the mTOR pathway in low and high grade endometrial carcinomas in a cohort of consecutive women. Occurrence of PIK3CA and K-Ras mutations and microsatellite instability. Histology and Histopathology 29(11): 1455-1466, 2015

Somatic mutations of target genes induced by DNA damage occur in endometrial carcinomas with microsatellite instability. Proceedings of the American Association for Cancer Research Annual Meeting 42: 903, March, 2001

APC and CTNNB1 mutations in a large series of sporadic colorectal carcinomas stratified by the microsatellite instability status. Scandinavian Journal of Gastroenterology 37(10): 1184-1193, October, 2002